August, November and December have been the most fruitful months of the year for novel drug approvals over the past decade, a Pink Sheet US Food and Drug Administration Performance Tracker analysis found.
US FDA’s Novel Approvals Peak Near Year-End, Analysis Of Last Decade Suggests
The Center for Drug Evaluation and Research’s novel approvals concentrated in August, November, and December, while January and June were the slowest months, according to a Pink Sheet analysis of 2014-2023 data.
